A real world lab message with non-standard date/time format

An example of real world lab message. Notice the non standard date/time format?

MSH|^~\&|FDHL7|JOHNSON LABS||P1055|201007231634||ORU^R01|P1055-0000047907|P|2.3|1||NE|NE
PID|1|JQ4988|108512373||SAMPLES^JUNIOR||01/10/1948^53 Y|M|||^******^^||||||||
NTE|1|P|****************************************************************************
ADD|NON FASTING
OBR|1||108512373|CHEM^-------* CHEMISTRY *--------||201007221041||||||||201007222312||P1055^SCI DULUTH/PHS^RTE 29,PO BOX 244^DULUTH, MN 19426^|(945)443-1234|RECEPTION, NEW||||201007231634|||R||||
OBX|1|NM|0135-4^Total Protein||7.3|gm/dl|5.9-8.4||||F
OBX|2|NM|0033-1^Albumin||3.9|gm/dl|3.2-5.2||||F
OBX|3|NM|1753-3^Globulin||3.4|gm/dL|1.7-3.7||||F
OBX|4|NM|0641-1^A/G Ratio||1.1||1.1-2.9||||F
OBX|5|NM|1976-0^Glucose||296|mg/dL|70-99|HI|||F
OBX|6|NM|0148-7^Sodium||134|mmol/L|133-145||||F
OBX|7|NM|0129-7^Potassium||4.3|mmol/L|3.3-5.3||||F
OBX|8|NM|0057-0^Chloride||96|mmol/L|96-108||||F
OBX|9|NM|0052-1^CO2||24|mmol/L|21-29||||F
OBX|10|NM|0049-7^BUN||17|mg/dl|7-25||||F
OBX|11|NM|0070-3^Creatinine||1.1|mg/dl|0.6-1.3||||F
OBX|12|NM|090013-4^e-GFR||70||> 60 mL/min/1.73m2||||F
OBX|13|NM|1427-4^BUN/Creat Ratio||15.5||10-28||||F
OBX|14|NM|0050-5^Calcium||8.9|mg/dl|8.4-10.4||||F
OBX|15|NM|0157-8^Uric Acid||6.2|mg/dl|2.4-7.0||||F
OBX|16|NM|0114-9^Iron||87|mcg/dl|30-160||||F
OBX|17|NM|0043-0^Bilirubin, Total||0.6|mg/dl|0.1-1.0||||F
OBX|18|NM|0117-2^LDH||190|u/l|94-250||||F
OBX|19|NM|0185-9^Alk Phos||63|u/l|39-120||||F
OBX|20|NM|0146-1^AST (SGOT)||33|u/l|0-37||||F
OBX|21|NM|0127-1^Phosphorous||2.8|mg/dl|2.6-4.5||||F
OBX|22|NM|0147-9^ALT (SGPT)||55|u/L|0-40|HI|||F
OBX|23|NM|0093-5^G-GTP||33|u/L|7-51||||F
NTE|1|L|****************************************************************************
ADD|GFR (Glomerular Filtration Rate) calculation utilizes the MDRD formula
ADD|(Modification of Diet in Renal Disease Study Group) and assumes a normal
ADD|adult body surface area of 1.73.  If the patient is African American
ADD|multiply result reported by 1.21. (Ref. National Kidney Disease Educa.
ADD|Program.)
ADD|       ***** Male/Female reference range:  >60 mL/min/1.73 m2 *****
ADD|Note: A calculated GFR of <60 mL suggests chronic kidney disease, but
ADD|only if found consistently over at least 3 months.  A calculated
ADD|result of <15 mL is consistent with renal failure.
OBR|2||108512373|CARD^-* CARDIOVASCULAR/LIPIDS *--||201007221041||||||||201007222312||P1055^SCI DULUTH/PHS^RTE 29,PO BOX 244^DULUTH, MN 19426^|(945)443-1234|RECEPTION, NEW||||201007231634|||R||||
OBX|1|NM|0058-8^Cholesterol||124|mg/dl|< 200||||F
OBX|2|NM|0155-2^Triglycerides||73|mg/dl|< 151||||F
OBX|3|NM|0059-6^HDL CHOL.,DIRECT||39|mg/dl|>40|LO|||F
OBX|4|NM|1764-0^HDL as % of Cholesterol||31|%|||||F
NTE|1|L|Range/Evaluation:  (> 25)     BELOW AVERAGE RISK
OBX|5|NM|1421-7^Chol/HDL Ratio||3.18| |||||F
NTE|1|L|Range/Evaluation:  (<4.2)     BELOW AVERAGE RISK
OBX|6|NM|0253-5^LDL/HDL Ratio||1.82| |0-3.55||||F
OBX|7|NM|0505-8^LDL Cholesterol||71||< 100||||F
OBX|8|NM|3345-6^VLDL, CALCULATED||14|mg/dl|7-32||||F
OBR|3||108512373|HEMA^------* HEMATOLOGY *--------||201007221041||||||||201007222312||P1055^SCI DULUTH/PHS^RTE 29,PO BOX 244^DULUTH, MN 19426^|(945)443-1234|RECEPTION, NEW||||201007231634|||R||||
OBX|1|NM|1497-7^WBC||6.61|x10(3)/uL|3.40-11.80||||F
OBX|2|NM|1498-5^RBC||4.56|x10(6)/uL|4.20-5.90||||F
OBX|3|NM|1499-3^HGB||13.6|gm/dL|12.3-17.0||||F
OBX|4|NM|0019-0^HCT||39.9|%|39.3-52.5||||F
OBX|5|NM|1503-2^MCV||87.5|fL|80.0-100.0||||F
OBX|6|NM|1504-0^MCH||29.8|pg|25.0-34.1||||F
OBX|7|NM|1502-4^MCHC||34.1|gm/dL|29.0-35.0||||F
OBX|8|NM|1598-2^RDW||14.1|%|10.9-16.9||||F
OBX|9|NM|1505-7^POLYS||58.8|%|36.0-78.0||||F
OBX|10|NM|3176-5^POLYS, ABS. COUNT||3.89|x10(3)/uL|1.22-9.20||||F
OBX|11|NM|1507-3^LYMPHS||31.0|%|12.0-48.0||||F
OBX|12|NM|3177-3^LYMPHS, ABS. COUNT||2.05|x10(3)/uL|0.41-5.66||||F
OBX|13|NM|1511-5^MONOS||7.7|%|0.0-13.0||||F
OBX|14|NM|3180-7^MONOS, ABS. COUNT||0.51|x10(3)/uL|0.17-1.42||||F
OBX|15|NM|1509-9^EOS||2.0|%|0.0-8.0||||F
OBX|16|NM|3178-1^EOS, ABS. COUNT||0.13|x10(3)/uL|0.03-0.94||||F
OBX|17|NM|1510-7^BASOS||0.3|%|0.0-2.0||||F
OBX|18|NM|3179-9^BASOS, ABS. COUNT||0.02|x10(3)/uL|0.00-0.24||||F
OBX|19|NM|270053-2^IMMATURE GRANULOCYTES||0.2|%|0.0-0.5||||F
OBX|20|NM|0128-9^PLATELET COUNT||191|x10(3)/uL|144-400||||F
OBX|21|NM|400053-5^MPV||10.6|fL|8.2-11.9||||F
OBR|4||108512373|URIN^------* URINALYSIS *--------||201007221041||||||||201007222312||P1055^SCI DULUTH/PHS^RTE 29,PO BOX 244^DULUTH, MN 19426^|(945)443-1234|RECEPTION, NEW||||201007231634|||R||||
OBX|1|ST|6315-6^Color||YELLOW||YELLOW, STRAW, AMBER||||F
OBX|2|ST|6316-4^Character||CLEAR||CLEAR||||F
OBX|3|NM|1520-6^Specific Gravity URN||1.030||1.003 - 1.030||||F
OBX|4|NM|1521-4^pH Urine||5.5||5.0 - 8.0||||F
OBX|5|ST|1522-2^Protein, Urine||NEGATIVE||NEGATIVE||||F
OBX|6|ST|1523-0^Glucose, Urine||3+,>=1000 mg/dL||NEGATIVE|*|||F
OBX|7|ST|1524-8^Ketone, Urine||NEGATIVE||NEGATIVE||||F
OBX|8|NM|1525-5^Urobilinogen Urine||1.0|Units|0.2 - 1.0||||F
OBX|9|ST|1526-3^Bilirubin, Urine||NEGATIVE||NEGATIVE||||F
OBX|10|ST|1527-1^Blood, Urine||NEGATIVE||NEGATIVE||||F
OBX|11|ST|1528-9^Nitrites Urine||NEGATIVE||NEGATIVE||||F
OBX|12|ST|6311-5^Leukocyte Esterase||NEGATIVE||NEGATIVE||||F
OBX|13|ST|1529-7^Crystals Urine||NONE||NONE||||F
OBX|14|ST|2135-2^Crystal Amt. Urine||NONE||NONE||||F
OBX|15|ST|1534-7^WBC, Urine||0-4|PER HPF|0-4||||F
OBX|16|ST|1535-4^RBC, Urine||0-3|PER HPF|0-3||||F
OBX|17|ST|1546-1^Epithelial Cells, Ur||FEW||FEW||||F
OBX|18|ST|1545-3^Cast, Hyaline, Urine||NONE SEEN|PER LPF|0-4||||F
OBX|19|ST|1547-9^Cast, Granular, Urin||NONE SEEN|PER LPF|0-1||||F
OBX|20|ST|1543-8^Cast, RBC, Urine||NONE SEEN|PER LPF|0-1||||F
OBX|21|ST|1549-5^Bacteria, Urine||NONE||FEW||||F
NTE|1|L|****************************************************************************
ADD|NOTE:  Significant quantities of epithelial cells will
ADD|be identified if they are not squamous cell types.
OBR|5||108512373|MISC^-----* MISCELLANEOUS *------||201007221041||||||||201007222312||P1055^SCI DULUTH/PHS^RTE 29,PO BOX 244^DULUTH, MN 19426^|(945)443-1234|RECEPTION, NEW||||201007231634|||R||||
OBX|1|NM|0153-7^TSH||1.930||0.27-4.2 uIU/mL||||F
OBX|2|NM|0151-1^THYROXINE(T4)||9.3||4.5-12.0 ug/dL||||F
OBX|3|NM|0152-9^T3 UPTAKE||29.7||24.3-39.0%||||F
OBX|4|NM|0666-8^FREE T4 INDEX||2.8| |1.1-4.5||||F
OBX|5|ST|0142-0^RPR||NON-REACT||NON-REACTIVE||||F
NTE|1|L|****************************************************************************
ADD|NOTICE: IF the result of the RPR is reported as reactive with a titer
ADD|of up to 1:8 please note that this level of reactivity can be caused
ADD|by other, non-specific constituents and may not be related to syphilis.
ADD|Confirmation of positive RPRs can only be made via performance of the  
ADD|T. Pallidum confirmation test.
OBX|6|NM|0102-4^HGB. A1c(glycohgb)||9.1||4-6%|HI|||F
OBX|7|ST|1661-8^CREAT.URN.TIMED/RAND||.147||gms/dL||||F
OBX|8|NM|2699-7^MICROALB/CREAT RATIO||4.1||<30mg/gm creat.||||F
OBX|9|NM|3172-4^MICROALBUMIN,RANDOM||0.6||<2.9 mg/dL||||F
NTE|2|L|****************************************************************************
ADD|GLYCOHEMOGLOBIN(HgbA1c)Ranges%  eAG ranges(mg/dL)* GLUCOSE CONTROL INDEX
ADD|      
ADD|      < 4-6%                      <68-126           Non-Diabetic Level
ADD|      < 6-7%                      <126-154          Diabetic Control
ADD|      > 8%                        >183        Additional action suggested
ADD|*Data adapted from the A1c-Derived Average Glucose (ADAG) Study 
ADD|(2006-2008). Estimated average glucose (eAG) values (shown as ranges
ADD|in the above table) can be reported as individual patient values if 
ADD|requested.
NTE|3|L|****************************************************************************
ADD|NOTE: SST tube submitted was inadequately spun. Serum was found to
ADD|contain RBCs. Certain tests, e.g. Glucose, may be decreased while
ADD|others e.g. Potassium or LDH may be elevated.
FTS|1|END OF FILE